PF-Atlas › Clinical Trials › NCT04654481

Study of AffloVest in At-Risk Respiratory Patients During COVID-19 Pandemic

HCFWO · Not specified

Registry ID

NCT04654481

Phase

Not specified

Status

Terminated

Drug / intervention

HCFWO

Sponsor

Icahn School of Medicine at Mount Sinai

Start

2021-07-20

About this trial

HCFWO is evaluated in NCT04654481, a idiopathic pulmonary fibrosis study sponsored by Icahn School of Medicine at Mount Sinai. Current status: Terminated.

View NCT04654481 on ClinicalTrials.gov →

Explore related

All HCFWO trials All IPF trials

Medical disclaimer. This page summarizes public trial data for NCT04654481 for information only. It is not medical advice, an endorsement, or an offer to enroll. Confirm details on ClinicalTrials.gov and with a qualified physician.